Targeting glycolysis with 2-deoxy- d -glucose sensitizes primary cell cultures of renal cell carcinoma to tyrosine kinase inhibitors

ConclusionThis study presents a valuable tool to cultivate even uncommon and rare renal cancer subtypes and allows testing of targeted therapies as a personalized approach as well as testing new therapies such as glycolysis inhibition in an in vitro model.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research